Methods for selection of better male gamete cells

A pilot study of fresh TESA and microfluidics sperm on fresh ejaculate in sibling oocytes: outcomes & implications for patients with DFI above 30. - Not applicable

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/06/111938

Enrollment

186

Registered

2026-06-04

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N469- Male infertility, unspecified

Interventions

Intervention1: Sperm selection method: Testicular sperm aspiration: Sperm cells will be selected from testicular tissue Intervention2: Sperm selection method: Microfluidic based sperm selection: Sperm

Eligibility

Inclusion criteria

Inclusion criteria: a) Sperm DFI above 30 c) ICSI cycles- both self & donor oocytes

Exclusion criteria

Exclusion criteria: a) Severe OATZ b) Low ovarian reserve c) Donor sperm d) MTESE Cycle type : Self-gamete & Donor oocyte cycles with no Pre implantation genetic testing for aneuploidy (PGT-A)

Design outcomes

Primary

Measure	Time frame
Top quality blastocysts and Clinical Pregnancy rates Timepoint: 1 years after the enrolment	—

Secondary

Measure	Time frame
1. Miscarriage rates 2. Live birth rates 3. Fertilization ratesTimepoint: 1 years after the enrolment	—

Countries

India

Contacts

Public ContactKrishna Chaitanya Mantravadi

Oasis Fertility, Hyderabad

krishna@oasisindia.in80088129993

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026